Q & M Dental Singapore : Initial Public Offering of Aoxin Q & M Dental Group Limited
April 26, 2017 at 08:45 am EDT
Share
Q & M DENTAL GROUP (SINGAPORE) LIMITED
(Company Registration No. 200800507R) (Incorporated in the Republic of Singapore)
INITIAL PUBLIC OFFERING OF AOXIN Q & M DENTAL GROUP LIMITED
LISTING OF AOXIN Q & M DENTAL GROUP LIMITED ("AQMD")
The board of directors (the "Board" or the "Directors") of Q & M Dental Group (Singapore) Limited (the "Company") refers to its announcements (the "Previous Announcements") dated 10 June 2016, 13 October 2016, 3 March 2017, 31 March 2017, 18 April 2017 and 25 April 2017 in relation to, inter alia, the spin-off of the Company's dentistry and dental specialist services and dental equipment and supplies distribution businesses in the Northern PRC Region via the proposed listing of its subsidiary, AQMD on the Catalist Board (the "Catalist") of the Singapore Exchange Securities Trading Limited (the "SGX-ST") (the "Listing").
Unless otherwise stated, all capitalised terms used herein shall have the same meaning given to them in the Previous Announcements.
The Board is pleased to announce the initial public offering of AQMD of an aggregate of 57,000,000 Placement Shares at the issue price of S$0.20 per Share. All of AQMD's issued ordinary shares (including the Placement Shares) were listed on the Catalist on 26 April 2017 and trading of the Shares had commenced from 9.00 a.m. on the same date.
COMPANY'S SHAREHOLDINGS IN AQMD
Following the completion of the Placement and as at the date of this announcement, the Company retains a shareholding interest in AQMD of approximately 45.94%.
DIRECTORS' RESPONSIBILITY STATEMENT
The Directors collectively and individually accept full responsibility for the accuracy of the information given in this announcement and confirm after making all reasonable enquiries, that to the best of their knowledge and belief, this announcement constitutes full and true disclosure of all material facts about the Listing, the Company and its subsidiaries, and the Directors are not aware of any facts the omission of which will make any statement in this announcement misleading.
Where information in this announcement has been extracted from published or otherwise publicly available sources or obtained from a named source, the sole responsibility of the Directors has been to ensure that such information has been accurately and correctly extracted from those sources and/or reproduced in this announcement in its proper form and context.
CAUTIONARY STATEMENT
Shareholders and potential investors of the Company are advised to read this announcement and any further announcements by the Company carefully. Shareholders of the Company are advised to refrain from taking any action in respect of their securities in the Company which may be prejudicial to their interests, and to exercise caution when dealing in the securities of the Company. In the event of any doubt, shareholders of the Company should consult their stockbrokers, bank managers, solicitors, accountants or other professional advisers.
By Order of the Board
Q & M Dental Group (Singapore) Limited
Vitters Sim
Chief Financial Officer 26 April 2017
Q & M Dental Group (Singapore) Limited published this content on 26 April 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 April 2017 12:45:15 UTC.
Original documenthttp://ir.qandm.com.sg/attachment/2017042618103200871192.pdf
Public permalinkhttp://www.publicnow.com/view/BDFB568ACAE6AF2F5E435B4B1F3FBD2B63CB9792
Q & M Dental Group (Singapore) Limited is a Singapore-based private dental healthcare company. The principal activities of the Company are the provision of management and consultancy services and investment holding. The Company operates through three segments: Primary Healthcare, Dental Equipment and Supplies Distribution, and Medical Laboratory. The Primary Healthcare segment comprises dentistry, family medicine, aesthetic services and others. The Dental Equipment and Supplies Distribution segment comprises the distribution of dental supplies and equipment. The Medical Laboratory segment comprises the sale and distribution of Covid-19 test kits and the provision of laboratory testing. It offers medical services, which include general health services, preventive care, vaccinations, extensive medical check-ups, minor procedures and covid-19. Its dental services include aesthetic/cosmetic dentistry, orthodontics (braces), teeth whitening, crowns and bridges and oral surgery.